Clinical trial
Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome
NCT00138528 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome
- Lead sponsor
- Novartis
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2004
- Completion date
- February 28, 2006
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.